Related Experiment Video
Updated: Apr 23, 2026

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Neoplasia following use of BMPs: is there an increased risk?
Ippokratis Pountos1, Michalis Panteli, Theodora Georgouli
1University of Leeds, School of Medicine, Academic Department of Trauma and Orthopaedics , Leeds, LS1 3EX , UK pountos@doctors.org.uk.
Introduction:
Bone morphogenetic proteins are multi-functional growth factors, which play an important role in embryonic development and cellular functions. Among several molecules in this family, BMP-2 and BMP-7 are currently being used in the clinical setting. Main clinical targets include the treatment of non-union, open fractures and spinal fusion. Their use has not been without complications, one of which might be a carcinogenic effect.
Areas Covered:
The authors offer a comprehensive review of the existing literature on the clinical studies analysing the role of bone morphogenetic proteins (BMPs) on carcinogenesis. The authors analyse the available literature and describe potential signalling pathways that can be affected as per available experimental in vitro and in vivo models.
Expert Opinion:
The available experimental data and clinical evidence are rather inadequate to allow any safe scientific conclusions. Clinical studies provide incomplete evidence to support the hypothesis that BMPs are carcinogenic. The available literature has several limitations including incomplete documentation, unreported data and inhered bias as a large number of trials have been funded by the industry. The need of well-structured studies is essential to address these safety concerns.
Insights
Bone morphogenetic proteins (BMPs) are used clinically, but their potential carcinogenic effects require further investigation. Current evidence is insufficient to confirm BMPs cause cancer, necessitating well-designed studies to address safety concerns.
Area of Science:
- Biomedical research
- Oncology
- Regenerative medicine
Background:
- Bone morphogenetic proteins (BMPs) are vital growth factors in development and cellular functions.
- BMP-2 and BMP-7 are clinically applied for non-union, fractures, and spinal fusion.
- Potential carcinogenic effects of BMPs represent a significant clinical concern.
Purpose of the Study:
- To comprehensively review existing literature on BMPs and carcinogenesis.
- To analyze clinical studies and experimental models regarding BMPs' role in cancer.
- To identify potential signaling pathways involved in BMP-induced carcinogenesis.
Main Methods:
- Literature review of clinical studies on BMPs and cancer.
- Analysis of in vitro and in vivo experimental models.
- Examination of potential molecular mechanisms and signaling pathways.
Main Results:
- Existing clinical data is insufficient to conclude BMPs are carcinogenic.
- Incomplete documentation, bias, and industry funding limit current study evidence.
- Experimental models suggest potential pathways but require further validation.
Conclusions:
- Current evidence does not support a definitive link between BMPs and cancer.
- Limitations in existing studies necessitate caution.
- Well-structured research is crucial to resolve safety concerns regarding BMPs.
More Related Videos
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
Related Concept Videos
Bone Remodeling and Repair
Bone Remodeling
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
Bone Formation by Endochondral Ossification
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...